Members, who have been
appointed for the length
of the pilot project, are: Eric Schadt, Ph.D. (Chair), chief scientific officer, Pacific Biosciences, Menlo Park, Calif.; Kevin K. Brown, M.D., professor and vice
chairman,
Department of Medicine, National Jewish Health, Denver; Vivian G. Cheung, M.D., professor, pediatrics and genetics, University of Pennsylvania School of Medicine and Howard Hughes Medical Institute, Philadelphia; Ross Hardison, Ph.D., professor, biochemistry and molecular biology, The Pennsylvania State University, University Park; Allan Jones, Ph.D., chief executive officer, Allen Institute for Brain Science, Seattle; Rebecca Pentz, Ph.D., professor of research ethics, department of hematology - oncology, Emory University School of Medicine, Atlanta; David L. Rimm, M.D., Ph.D., professor, pathology, Yale University School of Medicine, New Hav
Department of Medicine, National Jewish Health, Denver; Vivian G. Cheung, M.D., professor, pediatrics and genetics, University
of Pennsylvania School
of Medicine and Howard Hughes Medical Institute, Philadelphia; Ross Hardison, Ph.D., professor, biochemistry and molecular biology, The Pennsylvania State University, University Park; Allan Jones, Ph.D., chief executive officer, Allen Institute for Brain Science, Seattle; Rebecca Pentz, Ph.D., professor
of research ethics,
department of hematology - oncology, Emory University School of Medicine, Atlanta; David L. Rimm, M.D., Ph.D., professor, pathology, Yale University School of Medicine, New Hav
department of hematology - oncology, Emory University School
of Medicine, Atlanta; David L. Rimm, M.D., Ph.D., professor, pathology, Yale University School
of Medicine, New Haven, Conn..